Corriveau M L, Rosen B J, Keller C A, Chun D S, Dolan G F
Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center, St. Louis, Missouri.
Am Rev Respir Dis. 1988 Dec;138(6):1494-8. doi: 10.1164/ajrccm/138.6.1494.
A transient relationship between change in cardiac output (CO) and ventilation and a steady-state relationship between VCO2 and ventilation has been documented. We sought to evaluate the steady-state relationship between CO, and minute ventilation (VE) after positional change and after vasodilator administration in 24 patients with chronic obstructive pulmonary disease (COPD) and mild pulmonary hypertension. Cardiac output was 25% higher (p = 0.003) and VE was 25% lower (p = 0.0001) in the supine position. The change in VE showed a strong correlation with the change in VCO2 (r = 0.693; p = 0.0004), but not with the change in CO. Twelve patients received hydralazine 200 mg orally over 24 h, and 12 patients received nifedipine as a single 10-mg oral dose. Cardiac output increased from 5.05 +/- 1.25 L/min to 6.91 +/- 2.07 L/min (p = 0.008) after hydralazine and increased from 4.34 +/- 1.47 L/min to 5.85 +/- 2.15 L/min (p = 0.001) after nifedipine. Minute ventilation increased from 14.8 +/- 3.0 L/min to 17.3 +/- 4.4 L/min (p = 0.008) after hydralazine, but did not change after nifedipine. The change in VE showed a strong correlation with the change in VCO2 after hydralazine (r = 0.889; p = 0.0004) and after nifedipine (r = 0.756; p = 0.005), but did not correlate with the change in CO. These data demonstrate that the change in VE that accompanies positional change or vasodilator administration in patients with COPD is strongly correlated with the change in VCO2 but not with the change in CO when measured under steady-state conditions.
心输出量(CO)变化与通气之间的短暂关系以及二氧化碳排出量(VCO2)与通气之间的稳态关系已被记录。我们试图评估24例慢性阻塞性肺疾病(COPD)和轻度肺动脉高压患者在体位改变后以及使用血管扩张剂后CO与分钟通气量(VE)之间的稳态关系。仰卧位时心输出量高25%(p = 0.003),VE低25%(p = 0.0001)。VE的变化与VCO2的变化呈强相关(r = 0.693;p = 0.0004),但与CO的变化无关。12例患者在24小时内口服200毫克肼屈嗪,12例患者口服单次10毫克硝苯地平。服用肼屈嗪后,心输出量从5.05±1.25升/分钟增加到6.91±2.07升/分钟(p = 0.008),服用硝苯地平后,心输出量从4.34±1.47升/分钟增加到5.85±2.15升/分钟(p = 0.001)。服用肼屈嗪后,分钟通气量从14.8±3.0升/分钟增加到17.3±4.4升/分钟(p = 0.008),但服用硝苯地平后未改变。服用肼屈嗪后(r = 0.889;p = 0.0004)和服用硝苯地平后(r = 0.756;p = 0.005),VE的变化与VCO2的变化呈强相关,但与CO的变化无关。这些数据表明,COPD患者在体位改变或使用血管扩张剂时伴随的VE变化与VCO2的变化密切相关,但在稳态条件下测量时与CO的变化无关。